Silverarc Capital Management, LLC Ayala Pharmaceuticals, Inc. Transaction History

Silverarc Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.32 - $12.45 $340,753 - $509,902	-40,956 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.13 - $14.09 $143,022 - $247,871	17,592 Added 75.3%	40,956 $464,000
Q2 2021 Aug 16, 2021	BUY	$9.2 - $11.3 $214,948 - $264,013	23,364 New	23,364 $238,000

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.